Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 13;10(12):2521.
doi: 10.3390/healthcare10122521.

Application of Prenatal Whole Exome Sequencing for Structural Congenital Anomalies-Experience from a Local Prenatal Diagnostic Laboratory

Affiliations

Application of Prenatal Whole Exome Sequencing for Structural Congenital Anomalies-Experience from a Local Prenatal Diagnostic Laboratory

Theodora Hei Tung Lai et al. Healthcare (Basel). .

Abstract

Fetal structural congenital abnormalities (SCAs) complicate 2-3% of all pregnancies. Whole-exome sequencing (WES) has been increasingly adopted prenatally when karyotyping and chromosomal microarray do not yield a diagnosis. This is a retrospective cohort study of 104 fetuses with SCAs identified on antenatal ultrasound in Hong Kong, where whole exome sequencing is performed. Molecular diagnosis was obtained in 25 of the 104 fetuses (24%). The highest diagnostic rate was found in fetuses with multiple SCAs (29.2%), particularly those with involvement of the cardiac and musculoskeletal systems. Variants of uncertain significance were detected in 8 out of the 104 fetuses (7.7%). Our study shows the utility of WES in the prenatal setting, and the extended use of the technology would be recommended in addition to conventional genetic workup.

Keywords: genetic counselling; prenatal diagnosis; prenatal whole exome sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Persson M., Cnattingius S., Villamor E., Söderling J., Pasternak B., Stephansson O., Neovius M. Risk of major congenital malformations in relation to maternal overweight and obesity severity: Cohort study of 1.2 million singletons. BMJ. 2017;357:j2563. doi: 10.1136/bmj.j2563. - DOI - PMC - PubMed
    1. Committee on Genetics and the Society for Maternal-Fetal Medicine Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology. Obs. Gynecol. 2016;128:e262–e268. doi: 10.1097/AOG.0000000000001817. - DOI - PubMed
    1. Hillman S.C., Pretlove S., Coomarasamy A., McMullan D.J., Davison E.V., Maher E.R., Kilby M.D. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: A systematic review and meta-analysis. Ultrasound Obs. Gynecol. 2011;37:6–14. doi: 10.1002/uog.7754. - DOI - PubMed
    1. Callaway J.L., Shaffer L.G., Chitty L.S., Rosenfeld J.A., Crolla J.A. The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: A review of the literature. Prenat. Diagn. 2013;33:1119–1123. doi: 10.1002/pd.4209. - DOI - PMC - PubMed
    1. Kan A.S., Lau E.T., Tang W.F., Chan S.S., Ding S.C., Chan K.Y., Lee C.P., Hui P.W., Chung B.H., Leung K.Y., et al. Whole-genome array CGH evaluation for replacing prenatal karyotyping in Hong Kong. PLoS ONE. 2014;9:e87988. doi: 10.1371/journal.pone.0087988. - DOI - PMC - PubMed

LinkOut - more resources